Stephanie Klein Email

Director Administration . InSitu Biologics

Current Roles

Employees:
15
Revenue:
$3M
About
InSitu Biologics, LLC is an emerging biotech company focusing on development of new and proprietary treatments using its Matrixâ„¢ BioHydrogel. Their lead product, AnestaGelâ„¢, is a long-lasting and long-acting non-opiate painkiller, targeted for use in peri-operative regional pain management. AnestaGelâ„¢ uses a novel approach to delivering sustained-released analgesics into the target tissue via the Matrixâ„¢ BioHydrogel platform, which is a tunable, biocompatible, and pH neutral platform. This allows AnestaGelâ„¢ to provide target site-specific, non-migratory placement, a flexible and high dose drug-load reservoir capacity, and a tunable and predictable pharmacological effect.
InSitu Biologics Address
2155 Woodlane Drive
Woodbury, MN
United States
InSitu Biologics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.